©1996-2019. All Rights Reserved. Online Journal of Bioinformatics . You may not store these pages in any form
except for your own personal use. All other usage or distribution is illegal
under international copyright treaties. Permission to use any
of these pages in any other way besides the before mentioned must be gained in
writing from the publisher. This article is exclusively copyrighted in
its entirety to OJB publications. This article may be copied once but may not
be, reproduced or re-transmitted without the express permission of the editors.
This
journal satisfies the refereeing requirements (DEST) for the Higher Education
Research Data Collection (Australia). Linking:To link to this page or any pages linking to
this page you must link directly to this page only here rather than put up your
own page.
OJBTM
Online Journal of Bioinformatics ©
Volume 14(1):1-8, 2013
In silico analysis of flavopiridol analogues with Cdk2 in cancer therapy
Darakhshan Jabin
(M Sc), Ambarish Sharan Vidyarthi (PhD), Shankaracharya
(PhD) *
Department of
Biotechnology, Birla Institute of Technology, Mesra, Ranchi,
Jharkhand, India
Jabin D, Vidyarthi AS, Shankaracharya
S., In silico analysis of flavopiridol analogues with Cdk2 for cancer therapy, Online
J Bioinform., 14(1):1-8,
2013. Cyclin-dependent kinase 2 (CDK2) is essential for G1/S phase transitions of the cell cycle. Flavopiridol inhibits cancer
through interference with cyclin dependent kinases. Virtual screening and flexible docking using
GLIDE with ADME was used to predict 10 potential flavopiridol
analogues. From 500 compounds, ZINC_29557166 showed an interacting ligand with
cdk2 having a low GScore of - 8.78 satisfying all the
parameters of an ADME properties prediction.
Keywords: Flavopiridol,
Cdk2, Molecular Docking, ADME, Toxicity Prediction
FULL_TEXT(SUBSCRIPTION
OR PURCHASE TITLE $25USD)